相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data
Xin Hui S. Chan et al.
PLOS MEDICINE (2020)
Concentration-dependent mortality of chloroquine in overdose
James A. Watson et al.
ELIFE (2020)
Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial
Richard Kajubi et al.
LANCET (2019)
Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin-piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-label, superiority trial
Rukhsana Ahmed et al.
LANCET INFECTIOUS DISEASES (2019)
Predicting Optimal Dihydroartemisinin-Piperaquine Regimens to Prevent Malaria During Pregnancy for Human Immunodeficiency Virus-Infected Women Receiving Efavirenz
Erika Wallender et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis
Xin Hui S. Chan et al.
LANCET INFECTIOUS DISEASES (2018)
The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review
Ilsa L. Haeusler et al.
BMC MEDICINE (2018)
Different ways to estimate treatment effects in randomised controlled trials
J. Twisk et al.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2018)
Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women
Paul Natureeba et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review
Andreu Porta-Sanchez et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention
R. Kajubi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
The influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic review
Renee J. Burger et al.
MALARIA JOURNAL (2016)
Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy
Abel Kakuru et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Which QT Correction Formulae to Use for QT Monitoring?
Bert Vandenberk et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Population Pharmacokinetics, Tolerability, and Safety of Dihydroartemisinin-Piperaquine and Sulfadoxine-Pyrimethamine-Piperaquine in Pregnant and Nonpregnant Papua New Guinean Women
John M. Benjamin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Pharmacokinetics of drugs in pregnancy
Maisa Feghali et al.
SEMINARS IN PERINATOLOGY (2015)
Open-Label Crossover Study of Primaquine and Dihydroartemisinin-Piperaquine Pharmacokinetics in Healthy Adult Thai Subjects
Borimas Hanboonkunupakarn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Pharmacokinetic Interactions between Primaquine and Chloroquine
Sasithon Pukrittayakamee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Physiologic and pharmacokinetic changes in pregnancy
Maged M. Costantine
FRONTIERS IN PHARMACOLOGY (2014)
Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice
Geoffrey K. Isbister et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
QT interval prolongation and the risk of torsades de pointes: essentials for clinicians
Katy E. Trinkley et al.
CURRENT MEDICAL RESEARCH AND OPINION (2013)
Sex Hormones and the QT Interval: A Review
Tara Sedlak et al.
JOURNAL OF WOMENS HEALTH (2012)
Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial
Patrice Piola et al.
LANCET INFECTIOUS DISEASES (2010)
Community engagement on the Thai-Burmese border: rationale, experience and lessons learnt
Phaik Yeong Cheah et al.
INTERNATIONAL HEALTH (2010)
Population Pharmacokinetics of Lumefantrine in Pregnant Women Treated with Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria
Joel Tarning et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base
Olivier Bouchaud et al.
MALARIA JOURNAL (2009)
Randomized Trial of Artesunate plus Amodiaquine, Sulfadoxine-Pyrimethamine plus Amodiaquine, Chlorproguanal-Dapsone and SP for Malaria in Pregnancy in Tanzania
Theonest K. Mutabingwa et al.
PLOS ONE (2009)
A Randomised Controlled Trial of Artemether-Lumefantrine Versus Artesunate for Uncomplicated Plasmodium falciparum Treatment in Pregnancy
Rose McGready et al.
PLOS MEDICINE (2008)
Cardiotoxicity of antimalarial drugs
Nicholas J. White
LANCET INFECTIOUS DISEASES (2007)
The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria
Rose McGready et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Prognostic significance of corrected QT and corrected JT interval for incident coronary heart disease in a general population sample stratified by presence or absence of wide QRS complex - The ARIC study with 13 years of follow-up
RS Crow et al.
CIRCULATION (2003)
The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria
R McGready et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Risk of proarrhythmia with class III antiarrhythmic agents: Sex-based differences and other issues
DL Wolbrette
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Circadian rhythm of the corrected QT interval: Impact of different heart rate correction models
P Smetana et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2003)
Autonomic nervous system influences on QT interval in normal subjects
AR Magnano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome
MD Drici et al.
DRUG SAFETY (2001)
分享论文
